These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8296311)

  • 21. Legal Feasibility of US Government Policies to Reduce Cancer Risk by Reducing Intake of Processed Meat.
    Wilde P; Pomeranz JL; Lizewski LJ; Ruan M; Mozaffarian D; Zhang FF
    Milbank Q; 2019 Jun; 97(2):420-448. PubMed ID: 31016816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agency for Toxic Substances and Disease Registry Brownfields/ land-reuse site tool.
    Perlman GD; Berman L; Leann K; Bing L
    J Environ Health; 2012 Dec; 75(5):30-4. PubMed ID: 23270111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention, ethics and science: lessons from Lorenzo Tomatis.
    Zapponi GA; Marcello I; Carere A
    Ann Ist Super Sanita; 2008; 44(1):8-12. PubMed ID: 18469370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormesis: policy implications.
    Lave LB
    J Appl Toxicol; 2000; 20(2):141-5. PubMed ID: 10715612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency Response to Radiological Releases: Have We Communicated Effectively to the First Responder Communities to Prepare Them to Safely Manage These Incidents?
    Ingram RJ
    Health Phys; 2018 Feb; 114(2):208-213. PubMed ID: 30086017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Agency for Toxic Substances and Disease Registry's role in development and application of biomarkers in public health practice.
    Derosa CT; Stevens YW; Wilson JD; Ademoyero AA; Buchanan SD; Cibulas W; Duerksen-Hughes PJ; Mumtaz MM; Neft RE; Pohl HR
    Toxicol Ind Health; 1993; 9(6):979-94. PubMed ID: 8191504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification, characterization, and control of potential human carcinogens: a framework for Federal decision-making.
    Calkins DR; Dixon RL; Gerber CR; Zarin D; Omenn GS
    J Natl Cancer Inst; 1980 Jan; 64(1):169-76. PubMed ID: 6928042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seeking solutions to chemical mixtures challenges in public health.
    Mumtaz MM; Rosa CT; Cibulas W; Falk H
    Environ Toxicol Pharmacol; 2004 Nov; 18(2):55-63. PubMed ID: 21782735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
    MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topics in cancer risk assessment.
    Olin SS; Neumann DA; Foran JA; Scarano GJ
    Environ Health Perspect; 1997 Feb; 105 Suppl 1(Suppl 1):117-26. PubMed ID: 9114281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating a Biorepository Into the National Amyotrophic Lateral Sclerosis Registry.
    Horton DK; Kaye W; Wagner L
    J Environ Health; 2016 Nov; 79(4):38-40. PubMed ID: 28935999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative risk assessment and cost-benefit analysis for carcinogens at EPA: a critique.
    Perera FP
    J Public Health Policy; 1987; 8(2):202-21. PubMed ID: 3116042
    [No Abstract]   [Full Text] [Related]  

  • 36. Coordinating activities between NOAA and other agencies.
    Fritz AT; Buchman MF
    Drug Chem Toxicol; 1997 Nov; 20(4):307-12. PubMed ID: 9433660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk assessment in environmental policy-making.
    Russell M; Gruber M
    Science; 1987 Apr; 236(4799):286-90. PubMed ID: 3563508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical and radiation environmental risk management: differences, commonalities, and challenges.
    Tran NL; Locke PA; Burke TA
    Risk Anal; 2000 Apr; 20(2):163-72. PubMed ID: 10859777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key scientific findings and policy- and health-relevant insights from the U.S. Environmental Protection Agency's Particulate Matter Supersites Program and related studies: an integration and synthesis of results.
    Solomon PA; Hopke PK; Froines J; Scheffe R
    J Air Waste Manag Assoc; 2008; 58(13 Suppl):S3-92. PubMed ID: 19202993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.